As one of the leaders in the discovery and development of a new class of prognostic testing, Exagen Diagnostics is committed to providing additional information to physicians and patients in the fight against breast cancer. Using proprietary technology, the company identifies, validates and commercializes small sets of genomic markers, providing prognostic tests for use in commercial laboratories and for pharmaceutical use in clinical trials. Exagen Diagnostics is one of the leading developers of prognostic and predictive in vitro diagnostic kits. It aims to commercialize IVD kits to help launch new therapeutics. Exagen Diagnostics is located in Albuquerque, N.M.